The historical Coffin-Lowry syndrome family revisited

Identification of two novel mutations of RPS6KA3 in three male patients

Hiromi Koso Nishimoto, Kyungsoo Ha, Julie R. Jones, Alka Dwivedi, Hyun Min Cho, Lawrence C Layman, Hyung Goo Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Coffin-Lowry syndrome (CLS) is a rare X-linked dominant disorder characterized by intellectual disability, craniofacial abnormalities, short stature, tapering fingers, hypotonia, and skeletal malformations. CLS is caused by mutations in the Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) gene located at Xp22.12, which encodes Ribosomal S6 Kinase 2 (RSK2). Here we analyzed RPS6KA3 in three unrelated CLS patients including one from the historical Coffin-Lowry syndrome family and found two novel mutations. To date, over 140 mutations in RPS6KA3 have been reported. However, the etiology of the very first familial case, which was described in 1971 by Lowry with detailed phenotype and coined the term CLS, has remained unknown. More than 40 years after the report, we succeeded in identifying deposited fibroblast cells from one patient of this historic family and found a novel heterozygous 216bp in-frame deletion, encompassing exons 15 and 16 of RPS6KA3. Drop episodes in CLS patients were reported to be associated with truncating mutations deleting the C-terminal kinase domain (KD), and only one missense mutation and one single basepair duplication involving the C-terminal KD of RSK2 in the patients with drop episode have been reported thus far. Here we report the first in-frame deletion in C-terminal KD of RPS6KA3 in a CLS patient with drop episodes.

Original languageEnglish (US)
Pages (from-to)2172-2179
Number of pages8
JournalAmerican Journal of Medical Genetics, Part A
Volume164
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

Coffin-Lowry Syndrome
Mutation
Phosphotransferases
Craniofacial Abnormalities
Muscle Hypotonia
Missense Mutation
ribosomal protein S6 kinase, 90kDa, polypeptide 3
Intellectual Disability
Fingers
Exons
Fibroblasts
Phenotype

Keywords

  • Coffin-Lowry syndrome
  • Deletion
  • DGDP
  • Drop episode
  • Intellectual disability
  • Kinase Domain
  • RPS6KA3
  • RSK2

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

The historical Coffin-Lowry syndrome family revisited : Identification of two novel mutations of RPS6KA3 in three male patients. / Nishimoto, Hiromi Koso; Ha, Kyungsoo; Jones, Julie R.; Dwivedi, Alka; Cho, Hyun Min; Layman, Lawrence C; Kim, Hyung Goo.

In: American Journal of Medical Genetics, Part A, Vol. 164, No. 9, 01.01.2014, p. 2172-2179.

Research output: Contribution to journalArticle

Nishimoto, Hiromi Koso ; Ha, Kyungsoo ; Jones, Julie R. ; Dwivedi, Alka ; Cho, Hyun Min ; Layman, Lawrence C ; Kim, Hyung Goo. / The historical Coffin-Lowry syndrome family revisited : Identification of two novel mutations of RPS6KA3 in three male patients. In: American Journal of Medical Genetics, Part A. 2014 ; Vol. 164, No. 9. pp. 2172-2179.
@article{d62a940b85bb415e928b63badcf3c20b,
title = "The historical Coffin-Lowry syndrome family revisited: Identification of two novel mutations of RPS6KA3 in three male patients",
abstract = "Coffin-Lowry syndrome (CLS) is a rare X-linked dominant disorder characterized by intellectual disability, craniofacial abnormalities, short stature, tapering fingers, hypotonia, and skeletal malformations. CLS is caused by mutations in the Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) gene located at Xp22.12, which encodes Ribosomal S6 Kinase 2 (RSK2). Here we analyzed RPS6KA3 in three unrelated CLS patients including one from the historical Coffin-Lowry syndrome family and found two novel mutations. To date, over 140 mutations in RPS6KA3 have been reported. However, the etiology of the very first familial case, which was described in 1971 by Lowry with detailed phenotype and coined the term CLS, has remained unknown. More than 40 years after the report, we succeeded in identifying deposited fibroblast cells from one patient of this historic family and found a novel heterozygous 216bp in-frame deletion, encompassing exons 15 and 16 of RPS6KA3. Drop episodes in CLS patients were reported to be associated with truncating mutations deleting the C-terminal kinase domain (KD), and only one missense mutation and one single basepair duplication involving the C-terminal KD of RSK2 in the patients with drop episode have been reported thus far. Here we report the first in-frame deletion in C-terminal KD of RPS6KA3 in a CLS patient with drop episodes.",
keywords = "Coffin-Lowry syndrome, Deletion, DGDP, Drop episode, Intellectual disability, Kinase Domain, RPS6KA3, RSK2",
author = "Nishimoto, {Hiromi Koso} and Kyungsoo Ha and Jones, {Julie R.} and Alka Dwivedi and Cho, {Hyun Min} and Layman, {Lawrence C} and Kim, {Hyung Goo}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/ajmg.a.36488",
language = "English (US)",
volume = "164",
pages = "2172--2179",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - The historical Coffin-Lowry syndrome family revisited

T2 - Identification of two novel mutations of RPS6KA3 in three male patients

AU - Nishimoto, Hiromi Koso

AU - Ha, Kyungsoo

AU - Jones, Julie R.

AU - Dwivedi, Alka

AU - Cho, Hyun Min

AU - Layman, Lawrence C

AU - Kim, Hyung Goo

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Coffin-Lowry syndrome (CLS) is a rare X-linked dominant disorder characterized by intellectual disability, craniofacial abnormalities, short stature, tapering fingers, hypotonia, and skeletal malformations. CLS is caused by mutations in the Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) gene located at Xp22.12, which encodes Ribosomal S6 Kinase 2 (RSK2). Here we analyzed RPS6KA3 in three unrelated CLS patients including one from the historical Coffin-Lowry syndrome family and found two novel mutations. To date, over 140 mutations in RPS6KA3 have been reported. However, the etiology of the very first familial case, which was described in 1971 by Lowry with detailed phenotype and coined the term CLS, has remained unknown. More than 40 years after the report, we succeeded in identifying deposited fibroblast cells from one patient of this historic family and found a novel heterozygous 216bp in-frame deletion, encompassing exons 15 and 16 of RPS6KA3. Drop episodes in CLS patients were reported to be associated with truncating mutations deleting the C-terminal kinase domain (KD), and only one missense mutation and one single basepair duplication involving the C-terminal KD of RSK2 in the patients with drop episode have been reported thus far. Here we report the first in-frame deletion in C-terminal KD of RPS6KA3 in a CLS patient with drop episodes.

AB - Coffin-Lowry syndrome (CLS) is a rare X-linked dominant disorder characterized by intellectual disability, craniofacial abnormalities, short stature, tapering fingers, hypotonia, and skeletal malformations. CLS is caused by mutations in the Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3) gene located at Xp22.12, which encodes Ribosomal S6 Kinase 2 (RSK2). Here we analyzed RPS6KA3 in three unrelated CLS patients including one from the historical Coffin-Lowry syndrome family and found two novel mutations. To date, over 140 mutations in RPS6KA3 have been reported. However, the etiology of the very first familial case, which was described in 1971 by Lowry with detailed phenotype and coined the term CLS, has remained unknown. More than 40 years after the report, we succeeded in identifying deposited fibroblast cells from one patient of this historic family and found a novel heterozygous 216bp in-frame deletion, encompassing exons 15 and 16 of RPS6KA3. Drop episodes in CLS patients were reported to be associated with truncating mutations deleting the C-terminal kinase domain (KD), and only one missense mutation and one single basepair duplication involving the C-terminal KD of RSK2 in the patients with drop episode have been reported thus far. Here we report the first in-frame deletion in C-terminal KD of RPS6KA3 in a CLS patient with drop episodes.

KW - Coffin-Lowry syndrome

KW - Deletion

KW - DGDP

KW - Drop episode

KW - Intellectual disability

KW - Kinase Domain

KW - RPS6KA3

KW - RSK2

UR - http://www.scopus.com/inward/record.url?scp=84905909583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905909583&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.36488

DO - 10.1002/ajmg.a.36488

M3 - Article

VL - 164

SP - 2172

EP - 2179

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 9

ER -